Neuroradiology: Page 47

GE promotes DaTscan study results at AAN meeting
By AuntMinnieEurope.com staff writers
GE Healthcare is touting the results of a randomized study of DaTscan SPECT in adult patients with a diagnosis of possible dementia with Lewy bodies.
March 20, 2013
Piramal's florbetaben PET agent to be reviewed
By AuntMinnieEurope.com staff writers
Piramal Imaging said that the U.S. Food and Drug Administration and the European Medicines Agency have accepted the company's applications for review of its florbetaben investigational PET amyloid imaging agent.
March 20, 2013
Toshiba forms partnership to support dementia research
By AuntMinnieEurope.com staff writers
Toshiba Medical Systems has initiated a scientific partnership with VU Medical Center in Amsterdam for research into dementia and neurodegenerative disorders.
March 7, 2013
Hybrid brain imaging technique adds temporal dimension
By Jude Dineley
MRI/PET/electroencephalography hybrid scanning has been achieved for the first time by a group of researchers from Jülich in Germany, according to a recent article published online by the Journal of Magnetic Resonance, which describes the work being done and makes a case for multimodal imaging at 3 tesla and 9.4 tesla.
February 25, 2013
2013 02 25 10 55 52 627 2013 02 26 Hybrid Imaging Shah Pet Mr 20130225185313
Guidelines address nonsurgical stroke intervention
By AuntMinnieEurope.com staff writers
The Society of Interventional Radiology and several other medical societies have teamed to release new guidelines for interventional treatment of acute ischemic stroke.
February 5, 2013
Guidelines address nonsurgical stroke intervention
By AuntMinnieEurope.com staff writers
The Society of Interventional Radiology and several other medical societies have teamed to release new guidelines for interventional treatment of acute ischemic stroke.
February 5, 2013
Lilly's Amyvid PET agent gets European clearance
By AuntMinnieEurope.com staff writers
Eli Lilly and its subsidiary Avid Radiopharmaceuticals have received approval from the European Commission for their Amyvid (florbetapir F-18) radiopharmaceutical.
January 15, 2013
Lily gets EU approval for Amyvid PET radiotracer
By AuntMinnieEurope.com staff writers
Eli Lilly subsidiary Avid Radiopharmaceuticals has received marketing authorization from the European Commission for its Amyvid (florbetapir F-18) PET radiotracer.
January 15, 2013
Navidea reports completion of clinical trial
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals said that its partner AstraZeneca has completed a clinical trial of its NAV4694 radiopharmaceutical as a biomarker for visual detection and quantification of cerebral beta amyloid in diagnosing Alzheimer's disease.
January 14, 2013
French team determines cause of requests for urgent brain CT scans
By Rebekah Moan
Emergency brain CT scans are often requested for elderly patients with neurological deficits, acute cognitive disorders, or head trauma. Clinical signs of intracranial pathology are sometimes obvious but are more often lacking, French researchers have found.
January 13, 2013
2013 01 14 11 07 01 525 Philips Ct Heads Page4 Top Thumb
GE files applications for F-18 flutemetamol
By AuntMinnieEurope.com staff writers
The U.S. Food and Drug Administration and the European Medicines Agency have accepted applications from GE Healthcare for review of its investigational F-18 flutemetamol PET amyloid imaging agent.
January 7, 2013
High altitude sickness can lead to long-term brain damage
By Philip Ward
German researchers have used MRI to get a closer look at the potentially devastating neurological impact of high altitude sickness. In research presented at last week's RSNA congress, they showed that mountain climbers can have traces of bleeding in the brain years after the initial incident.
December 2, 2012
2012 12 03 09 25 25 383 Rock Climbing 70
Previous Page
Page 47 of 59
Next Page